...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Feb. 06, 2019 FMV ZENE!
2
Feb 07, 2019 12:11PM

Always remember that there is a difference between Fair Value and Fair Market Value. Zenith states that their Fair Value is exclusively for financials, "for financial reporting purposes." That is totally unrelated to market values. For a closely related example, RVX closed October 31 @ USD 2.53/sh. At that time, RVX reported share capital equal to USD 1.41/sh. 

2
Feb 07, 2019 01:33PM
2
Feb 07, 2019 02:09PM
2
Feb 07, 2019 02:42PM
2
Feb 07, 2019 02:59PM
1
Feb 07, 2019 03:18PM
1
Feb 07, 2019 03:55PM
2
Feb 07, 2019 04:13PM
3
Feb 07, 2019 05:50PM
2
Feb 07, 2019 05:57PM
Share
New Message
Please login to post a reply